Listen "S4 Episode 16 - Major IBD breakthroughs, developments, and news stories from 2025!"
Episode Synopsis
Send us a textWelcome to S4 episode 16! As we head towards the end of 2025, we wanted to cover IBD breakthroughs, treatment developments and other stories that were in the news. We felt these stories were important to share because a lot of times there are click bait stories out there that can be misleading. But most of all we think it is important to share the hope, support, and direction research is heading! We included links for further reading. We are family friendly and want our audience to be involved! Listen together, separately, but ultimately we hope we bring some attention to some well deserved topics on chronic illness.Links in episode: -https://newatlas.com/disease/obefazimod-daily-pill-ulcerative-colitis-clinical-trial/?-https://www.prnewswire.com/news-releases/icotrokinra-maintains-standout-combination-of-therapeutic-benefit-and-a-favorable-safety-profile-in-once-daily-pill-through-28-weeks-in-ulcerative-colitis-302594371.html?-https://www.cedars-sinai.org/newsroom/study-crohns-disease-investigational-treatment-shows-potential-for-achieving-remission/?-https://www.hmpgloballearningnetwork.com/site/aibdnet/news/fda-approves-updated-indication-upadacitinib-ibd?-https://www.investor.jnj.com/investor-news/news-details/2025/TREMFYA-guselkumab-achieves-U-S--approval-for-subcutaneous-induction-in-adults-with-ulcerative-colitis-now-the-first-and-only-IL-23-inhibitor-with-a-fully-subcutaneous-regimen/default.aspx?-https://www.gastroendonews.com/Inflammatory-Bowel-Disease/Article/11-25/Molecular-Biomarkers-IBD-Therapy/78819?-https://www.sciencedaily.com/releases/2025/11/251103093012.htm?-https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1517121/full?-https://innovationdistrict.childrensnational.org/growth-program-tackles-inflammatory-bowel-disease/?-https://www.barchart.com/story/news/35342504/ulcerative-colitis-pipeline-2025-moa-and-roa-insights-clinical-trials-status-and-key-companies-involved-by-delveinsight-nubiyota-adiso-therapeutics-landos-biopharma-prometheus-biosciences?-https://www.crohnscolitisfoundation.org/sites/default/files/2025-10/Impact%20Report_Fall_Winter%202025.pdf?utmwww.goodkarmastand.comhttps://www.karmatudecandles.com/karmatude-clipsFollow us on Instagram @TeamIBDetermined, @TheReggieProject, and @KarmatudeCandlesTo find out where to listen to our podcast visit https://www.buzzsprout.com/1911185To purchase IBDetermined t-shirts: https://www.bonfire.com/store/karmatude/To order candles:www.karmatudecandles.com
More episodes of the podcast IBDetermined
S4 Episode 15- It is IBD Awareness Week!
04/12/2025
S4 Episode 14 - We discuss the challenges of the holidays and offer solutions to help ease stress!
20/11/2025
S4 Episode 13 - Does having IBD mean catching colds and viruses more easily? What to know!
06/11/2025
S4 Episode 12 - Michelle is Volunteer of the Year & more about the Crohn's & Colitis Foundation Gala
23/10/2025
S4 Episode 11 - Methods to help relax and reduce anxiety at medical appointments and infusions!
09/10/2025
S4 Episode 10 - Thanks to a new initiative, hospitalizations and emergency room visits are 50% down!
24/09/2025
S4 Episode 9 - Navigating the ups and downs of dream granting organizations and IBD kids!
11/09/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.